Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,934 | -90,351 | -65,616 | -44,663 | -22,647 |
| Depreciation Amortization | 480 | -1,444 | -1,731 | -1,691 | -985 |
| Accounts payable and accrued liabilities | 2,422 | 627 | 218 | 719 | 1,694 |
| Other Working Capital | 1,173 | 268 | -3,080 | -1,815 | -1,414 |
| Other Operating Activity | 740 | 13,727 | 10,465 | 7,214 | 2,578 |
| Operating Cash Flow | $-26,119 | $-77,173 | $-59,744 | $-40,236 | $-20,774 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -281 | -1,183 | -1,055 | -928 | -780 |
| Purchase Of Investment | -83,479 | -269,513 | -226,750 | -149,367 | -88,965 |
| Sale Of Investment | 130,000 | 284,700 | 212,200 | 112,700 | 44,700 |
| Investing Cash Flow | $46,240 | $14,004 | $-15,605 | $-37,595 | $-45,045 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6 | -61 | -42 | -29 | -15 |
| Common Stock Issued | 201 | 30,730 | 9,976 | 87 | 19 |
| Other Financing Activity | 0 | -241 | -166 | 0 | 0 |
| Financing Cash Flow | $195 | $30,428 | $9,768 | $58 | $4 |
| Beginning Cash Position | 104,184 | 136,925 | 136,925 | 136,925 | 136,925 |
| End Cash Position | 124,500 | 104,184 | 71,344 | 59,152 | 71,110 |
| Net Cash Flow | $20,316 | $-32,741 | $-65,581 | $-77,773 | $-65,815 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,119 | -77,173 | -59,744 | -40,236 | -20,774 |
| Capital Expenditure | -281 | -1,183 | -1,055 | -928 | -780 |
| Free Cash Flow | -26,400 | -78,356 | -60,799 | -41,164 | -21,554 |